Pending authorization of the Omicron KP.2-adapted vaccine by the EC, both the Omicron KP.2-adapted vaccine and the Omicron JN.1-adapted vaccine will be available across the EU, though availability ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.

Roche (RHHBF) unit Genentech said Xofluza antiviral reached the main goal in a global Phase 3 trial, reducting the ...

CENTERSTONE is the first global Phase III study to show a transmission reduction benefit with an antiviral used in the treatment of a respiratory viral illness. This new data may add to the benefits ...

SWANTON — Three alumni from graduating classes in the 1990s and early 2000s were inducted into the Missisquoi Valley Union ...

Researchers reported at the ESMO Congress that 78 percent of patients responded to front-line treatment with Lumakras, ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...

MERGE, a premier storytelling technology company, announced the appointment of Jim Weiss, the visionary founder and chairman ...

Patient education could help clarify that remission in inflammatory bowel disease does not solely consist of resolved symptoms.

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...